撤回：微小RNA-340通过靶向BICD2抑制胰腺癌生长。 - Suppr | 超能文献

相似文献

1

WITHDRAWN: MicroRNA-340 suppresses pancreatic cancer growth by targeting BICD2.撤回：微小RNA-340通过靶向BICD2抑制胰腺癌生长。

Pancreatology. 2019 May 9. doi: 10.1016/j.pan.2019.05.453.

2

[Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].环状RNA BICD2对口腔鳞状细胞癌细胞生物学行为的影响及机制

Zhonghua Kou Qiang Yi Xue Za Zhi. 2021 Nov 9;56(11):1098-1108. doi: 10.3760/cma.j.cn112144-20210402-00160.

3

circ_BICD2 acts as a ceRNA to promote tumor progression and Warburg effect in oral squamous cell carcinoma by sponging miR-107 to enhance HK2.环状BICD2作为一种竞争性内源RNA，通过吸附miR-107增强己糖激酶2（HK2），从而促进口腔鳞状细胞癌的肿瘤进展和瓦伯格效应。

Am J Transl Res. 2020 Jul 15;12(7):3489-3500. eCollection 2020.

4

MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5.MicroRNA-301a 通过靶向 SOCS5 促进 JAK/STAT3 信号通路促进胰腺癌的侵袭和转移。

Carcinogenesis. 2020 Jun 17;41(4):502-514. doi: 10.1093/carcin/bgz121.

5

Reconstitution of the targeting of Rab6A to the Golgi apparatus in semi-intact HeLa cells: A role of BICD2 in stabilizing Rab6A on Golgi membranes and a concerted role of Rab6A/BICD2 interactions in Golgi-to-ER retrograde transport.在半完整的HeLa细胞中恢复Rab6A靶向高尔基体：BICD2在稳定Rab6A于高尔基体膜上的作用以及Rab6A/BICD2相互作用在高尔基体到内质网逆行转运中的协同作用。

Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2592-609. doi: 10.1016/j.bbamcr.2015.05.005. Epub 2015 May 9.

6

MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.微小RNA-410通过靶向胰腺癌中的血管紧张素II 1型受体发挥肿瘤抑制作用。

IUBMB Life. 2015 Jan;67(1):42-53. doi: 10.1002/iub.1342. Epub 2015 Feb 3.

7

microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.微小RNA-218通过靶向高迁移率族蛋白B1抑制胰腺癌细胞的增殖、侵袭并促进其凋亡。

Chin J Cancer Res. 2015 Jun;27(3):247-57. doi: 10.3978/j.issn.1000-9604.2015.04.07.

8

MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.MicroRNA-300 通过靶向胰腺癌细胞中的 CUL4B 促进细胞凋亡，抑制增殖、迁移、侵袭和上皮-间充质转化，通过 Wnt/β-catenin 信号通路。

J Cell Biochem. 2018 Jan;119(1):1027-1040. doi: 10.1002/jcb.26270. Epub 2017 Aug 23.

9

Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells.靶向反义长链非编码RNA PRKAG2-AS1作为一种治疗靶点可抑制肝癌细胞的恶性行为。

Front Med (Lausanne). 2021 Apr 13;8:649279. doi: 10.3389/fmed.2021.649279. eCollection 2021.

10

MicroRNA MiR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3.微小 RNA miR-490-5p 通过靶向 MAGI2 反义 RNA 3 调控上皮-间充质转化抑制胰腺癌。

Bioengineered. 2022 Feb;13(2):2673-2685. doi: 10.1080/21655979.2021.2024653.

引用本文的文献

1

A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment.外泌体和 microRNAs 在胰腺癌中作用的最新概述：诊断和治疗的前瞻性计划。

Int J Mol Sci. 2024 Mar 17;25(6):3406. doi: 10.3390/ijms25063406.

2

The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches.微小 RNA 和自噬机制在胰腺癌进展中的新作用：未来的治疗方法。

Genes (Basel). 2022 Oct 15;13(10):1868. doi: 10.3390/genes13101868.

3

Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells.